# First in Human Study of the DaVingi™ TR System in the Treatment of Patients With Functional Tricuspid Regurgitation

> **NCT03700918** · NA · UNKNOWN · sponsor: **Cardiac Implants LLC** · enrollment: 15 (estimated)

## Conditions studied

- Functional Tricuspid Regurgitation (TR)

## Interventions

- **DEVICE:** DaVingiTR System

## Key facts

- **NCT ID:** NCT03700918
- **Lead sponsor:** Cardiac Implants LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-11
- **Primary completion:** 2021-12
- **Final completion:** 2022-06
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2021-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03700918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03700918, "First in Human Study of the DaVingi™ TR System in the Treatment of Patients With Functional Tricuspid Regurgitation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03700918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*